Optimising the health of young people with HIV in their transition from paediatric to adult care
The aim of the CHIPS+ cohort is to evaluate the longer-term health outcomes of young people in adult care who have HIV acquired in childhood
What was this study about?
Due to improvements in HIV treatment and care, increasing numbers of children living with HIV are surviving into adulthood and transitioning from paediatric to adult care. Nevertheless, data collection in CHIPS (the Collaborative HIV Paediatric Study) ceases at time of transfer to adult care. Thus there is a substantial knowledge gap about long term health outcomes of this group in the UK and Ireland, and worldwide; through CHIPS+ we aim to bridge this gap.
What difference did this study make?
CHIPS+ is still in the recruitment phase. At present, no data have been published.
Type of study
Who funded the study?
CHIPS+ is linked to CHIPS and is funded via participation in European ART safety studies, themselves funded by pharmaceutical companies.
When did it take place?
July 2017 to December 2020
Where did it take place?
NHS clinics across the UK and Ireland
Who was included?
Patients aged ≥15 years who received paediatric HIV care in the UK or Ireland.